云南白药(000538) - 2025年4月1日投资者关系活动记录表

Group 1: Investor Relations Activity - The meeting involved 146 participants from various securities firms and individual investors [2] - The event was held at the company's headquarters on April 1, 2025 [2] Group 2: Company Representatives - Key representatives included Chairman Zhang Wenxue, President Dong Ming, and Chief Financial Officer Ma Jia [2] - Other senior executives present were from various business units, including pharmaceuticals and health products [2] Group 3: Meeting Objectives - The primary focus was to understand the company's operational status and financial data for the 2024 annual report [2]